PACB Jan 2024 42.000 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

1.5500

0.0000

(0.00%)

At close: 12:52PM EDT

Loading interactive chart...

Investing.com
Pacific Biosciences gains on TD Cowen upgrade, citing potential for sales growth
By Liz Moyer
Zacks
Does Pacific Biosciences (PACB) Have the Potential to Rally 30.15% as Wall Street Analysts Expect?
The mean of analysts' price targets for Pacific Biosciences (PACB) points to a 30.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Simply Wall St.
Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Worth US$8.8 Based On Its Intrinsic Value?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Pacific Biosciences of California fair value estimate is...